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Signal intensity analysis and optimization for in vivo imaging of 
Cherenkov and excited luminescence
Ethan P. M. LaRochelle, Jennifer R. Shell, Jason R. Gunn, Scott C. Davis, and Brian W. 
Pogue
Thayer School of Engineering, Dartmouth College, Hanover, NH 03755, USA
Abstract
During external beam radiotherapy (EBRT), in vivo Cherenkov optical emissions can be used as a 
dosimetry tool or to excite luminescence, termed Cerenkov-excited luminescence (CEL) with 
microsecond-level time-gated cameras. The goal of this work was to develop a complete 
theoretical foundation for the detectable signal strength, in order to provide guidance on 
optimization of the limits of detection and how to optimize imaging, near real time frame rates. 
The key parameters affecting photon production, propagation and detection were considered and 
experimental validation with both tissue phantoms and a murine model are shown. Both the 
theoretical analysis and experimental data indicate that the detection level is near a single photon-
per-pixel for the detection geometry and frame rates commonly used, with the strongest factor 
being the signal decrease with the square of distance from tissue to camera. Experimental data 
demonstrates how the SNR improves with increasing integration time, but only up to the point 
where the dominance of camera read noise is overcome by stray photon noise that cannot be 
suppressed. In a fixed geometry and camera, the signal to background ratio limits the detection of 
light signals, and the observed in vivo Cherenkov emission is on the order of 100× stronger than 
CEL signals. As a result, imaging signals from depths < 15mm is reasonable for Cherenkov light, 
and depths < 3mm is reasonable for CEL imaging. The current investigation modeled Cherenkov 
and CEL imaging of two oxygen sensing phosphorescent compounds, but the modularity of the 
code allows for easy comparison of different agents or alternative cameras, geometries or tissues.
Introduction
Cherenkov based dosimetry or luminescence imaging have recently been developed for 
sensing within a range of applications including radiation therapy dosimetry.1–6 This light 
intensity is an example of a signal that is linearly related to the applied radiation to the 
tissue.2,7 In general, the light signals available to be detected are quite low, being near the 
single photon per pixel level for most detection systems. The detection approaches to 
dealing with these signals are advanced, but the choice of ideal detection device strongly 
depends upon knowledge of the signal intensity, especially at this range where it could be 
below or above the single photon per pixel level.8 In this study, a rigorous theoretical 
analysis of the signal level available was completed and validated through both ex vivo and 
in vivo experiments, in order to assess where optimizations might best be made.
There are a number of single photon detection strategies using specialized signal processing 
to ensure that the signal read out from the camera is real, and not attributed to noise. One of 
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the dominant factors in deciding the detection scheme is the speed of readout desired, 
because the number of photons per pixel per unit time will affect the acceptable noise and 
readout noise. Long integration times of seconds to minutes can be achieved with low noise 
cameras such as a cooled CCD. However, when the readout time is the range of 
milliseconds, then the ideal choice might be a cooled sCMOS sensor. Yet again when the 
timing of acquisition needs to be in the microsecond range, then few options exist for this 
fast gating, other than a time-gated image intensifier. In the application of Cherenkov 
mediated imaging from a linear accelerator, this latter approach is required, with fast 
temporal gating, with on and off times in the nanosecond range. As result, much of this 
study focuses on an image intensified camera, where the initial detection event occurs at the 
entry photocathode, and after amplification, follows through to a phosphor plate.
The photon budget considers several parameters, including: the number of Cherenkov source 
photons, attenuation due to tissue optical properties, lens type and placement, photocathode 
quantum efficiency, micro-channel plate gain, phosphor plate quantum efficiency, and CCD 
efficiency. Noise introduced by the photocathode, CCD, and analog-to-digital converter 
(ADC) are also considered. Where possible, the budget tracks photon wavelength within the 
range of 350–900nm with 10nm resolution. A series of Python scripts were developed to 
track the photon counts at each stage, from Cherenkov emission through digitization at the 
ADC.
The scheme of how to maximize the signal to noise in these cameras depends upon a better 
understanding of the signal and noise levels. This current investigation provides the basis for 
a photon budget for both Cherenkov emission imaging, as well as Cherenkov excited 
luminescence (CEL) imaging from two phosphorescent compounds used experimentally. 
The work begins with an in depth theoretical treatment of all aspects of the imaging situation 
which affect the signal strength, and then progresses to experimental studies that are used to 
validate the predictions. Ultimately the results of this study can then guide optimization with 
this type of camera, or alternatively other detection systems which are optimized for single 
photon imaging.
Theory
Signal Source
Cherenkov photons are generated over a wide spectral range, but within the UV/optical/NIR 
range the distribution is proportional to 1/λ2, as described by the Frank-Tamm formula, 
which can be used to calculate the number of emitted Cherenkov photons for a given input 
phase velocity (β) and target refractive index (n).9,10 Extensive Monte Carlo simulations 
have been performed previously to relate the Cherenkov photon fluence to EBRT dose rates 
(Gy/sec).7 These spectrally-resolved photon fluence values can then be used to estimate the 
number of Cherenkov photons produced during CEL imaging.
CEL imaging relies upon the emission of Cherenkov photons to excite a localized 
phosphorescent compound within the medium. Unlike fluorescence imaging, which 
generally use an external light source for excitation, CEL is accomplished through the local 
production of photons within a target, such as tissue. Localized Cherenkov photons are 
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produced when high-energy charged particles, such as electrons, move through a dielectric 
medium at a speed faster than the phase velocity of light for the given target.9 For medical-
imaging applications the high-energy electron source is generally caused by either a 
radioisotope implanted in the target tissue,11–13 or from an external beam radiotherapy 
(EBRT).1,2,14 This paper will focus on the latter, although Monte Carlo simulations have 
been used to relate the photons generated by the two sources.7,15,16
Tissue Optical Properties
While the Cherenkov emission spectrum is heavily UV/blue-weighted, with in vivo imaging, 
much of this spectrum is attenuated due to tissue optical properties. Tissue is composed of 
several smaller structures, each with unique absorption and scattering properties. The bulk 
summation of these optical properties can be assessed based on estimates of the proportions 
of contributing factors such as hemoglobin, water, and lipids. These estimates can then be 
applied to Monte Carlo simulations for boundary interactions, or applied to diffusion theory 
estimates of light propagation deeper in tissue.
When Cherenkov photons are emitted deep within tissue, surface detection will be red-
shifted due to the light attenuation introduced by tissue.2 Additionally, the light scattering in 
tissue further increases pathlength of travel, compounding the absorption due to blood, and 
as a result the dominant light signal available is within the 650–950nm range. Since there are 
reduced numbers of Cherenkov photons in this part of the spectrum, the overall signal is 
reduced and the detection is more difficult. It has been a bit unclear if the optimal excitation 
of a CEL should be in the blue or red wavelengths, but recent data suggests that red 
excitation is superior to blue for maximal CEL signal.17 The red Cherenkov photons 
produced within tissue can be absorbed and re-emit photons at a longer NIR wavelength, 
which travel further in tissue. Several factors come into play when selecting an appropriate 
compound. As with fluorescence imaging, the quantum yield (Φ) of the compound is one 
important factor which dictates the efficiency of the compound. In CEL imaging time gating 
is used to separate Cherenkov emissions from luminescence, so phosphorescence lifetime 
(τ) is also an important factor. Medical Linear accelerators have a 3–4 microsecond radiation 
pulse, and so this moderate pulse time limits most time gating to the microsecond regime. 
The luminescent agents which are available with microsecond lifetimes are phosphorescent. 
It has not been feasible to detect fluorescent agents which by definition have nanosecond 
lifetimes, other than through wavelength filtering and continuous wave detection.17 In 
medical applications biocompatibility and the ability to target areas of interest are also 
important factors, however these are outside the scope of the current investigation.
Detection Hardware
In EBRT, a linear accelerator delivers 3–4 microsecond bursts of radiation at a specific duty 
cycle, often in the range of 100–400 Hz, which can be synchronized to the gating of the 
shutter of a sensitive camera. The speed of this gating is not conducive to mechanical 
shuttering, requiring the use of electronic gating approaches such as an image intensifier 
can. In previous work, an ICCD was chosen as the optimal camera for both sensitivity and 
time-gating reasons.8 This current investigation focuses on time-gated discrimination of 
Cherenkov emission and luminescence, and what level of signal is available within this 
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constraint, however the estimation of photon levels can also be applied to assess the 
applicability of other camera systems.
Camera position and lens selection are two factors that influence resolution, field of view, 
and photon sensitivity. Several other inherent camera properties can also influence detection. 
In an ICCD, the intensifier has three components: the photocathode, microchannel plate 
(MCP), and phosphor screen, which each play a role in the sensitivity. The photocathode 
converts photons to electrons by the photoelectric effect. Then a high voltage applied across 
the MCP attracts the electrons to the nearest channel, where they are multiplied through 
multiple wall collisions, often to 10,000× more than the entering electron numbers. This 
amplified electron flow then exits the MCP onto a phosphor screen, which converts these 
fast electrons into photons. The phosphor screens have a certain quantum efficiency (QE) for 
producing light from these electrons, and then this optical signal must be imaged by a 
camera, like a CCD or CMOS sensor, for pixelated electronic imaging. In the case studied 
here, the CCD converts these photons back to an electric charge, based on the QE of the 
sensor. Other CCD properties like dark current and full well capacity will also influence 
detection. The analog to digital converter (ADC) will also introduce a certain amount of 
uncertainty when quantizing the analog signal into bins with 16-bit resolution. The readout 
noise is also usually a dominant factor in what is detectable with a sensor, and so 
determining how fast to read the signal or how long to integrate for is often determined by 
the intensity of the signals on the chip.
Environmental conditions may also impact the ability to discriminate signal from 
background. While time-gating reduces the impact of ambient lighting during Cherenkov 
detection, ambient light is unnecessary background and often needs to be minimized. Within 
the ICCD a certain level of effective background illumination (EBI) will be introduced by 
the intensifier. Additionally, thermal dark noise (σD) and shot noise (σS) will be introduced 
by the CCD. For detection, usually the target signal must be greater the sum of the noise 
components, or else more elaborate methods for signal averaging or signal processing must 
be employed.
Methods
A photon budget for EBRT CEL imaging was developed based on previously reported 
camera configurations and imaging geometries. Estimates of photon counts were made 
between 350nm and 900nm with a 10nm resolution for each step in the Cherenkov and CEL 
imaging process. The estimates in the following section are for quanta (photons or electrons) 
as they travel from their source through the final step of being detected and digitized at a 
single (2×2-binned) pixel with the resolution of 315μm (0.1mm2).
The input parameters for each component in the imaging system are provided in the 
supplementary material (S1). Python code was developed to read this input file and 
determine the quanta at each stage based on the input radiation dose and total exposure time. 
The quanta for wavelengths of interest are recorded in an output file which is organized by 
tissue depth of the source photons. Output files were created for Cherenkov detection (S2), 
and phosphorescence detection (S3).
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Cherenkov
Previous Monte Carlo simulations documented by Glaser et al. 7 provide the fluence rate 
over a wide spectral range for Cherenkov photons produced in tissue as the result of an 
external 6MV X-ray photon beam. This average fluence rate (nW/cm2) is provided as a 
function of radiation dose rate (Gy/sec) and can be converted to photon flux (photons/cm2) 
by accounting for the energy at each wavelength. The photon flux is then dependent on the 
radiation dose rate, which can be simplified to be assumed at a standard 0.1Gy/sec (600MU/
min, the standard Monitor Unit rate of the Varian Clinac2100CD at 6MV). The Varian 
higher energy clinical linear accelerator (Clinac 2100C) referenced in previous CEL 
publications provides a 3–4μs radiation pulse at a variable repetition rate of 60Hz–360Hz, 
but commonly at 360 Hz for the higher MU/min.6,8,18
The number of Cherenkov photons can then be estimated for the area detected by a single 
pixel (0.1mm2) based on the total dose delivered. For simplicity, this is calculated for the 
following: a single pulse (0.028 cGy), 30 pulses (0.83 cGy), 60 pulses (1.67 cGy), and 7200 
pulses (2 Gy), where 2Gy is a typical daily dose given during fractionated radiotherapy.
Luminescence
The number of photons absorbed by a phosphorescent compound is governed by the molar 
extinction coefficient and concentration of the compound. The quantum yield provides a 
metric of how efficiently the compound emits photons when one is absorbed. Two 
phosphorescent compounds are considered in this photon budget: PtG4 (λEx: 435nm, 
623nm, λEm: 772nm)19 and Ir(btp)2(acac) (λEx: 337nm, 480nm, λEm: 620nm)20. It is 
assumed 50μL of a 50μM solution is injected into a tumor with a total volume of 250mm3. 
So, assuming the compound is distributed homogenously throughout the tumor and does not 
leak, the final concentration in the tumor would be 10uM or a total number of 0.25 
nanomols. Since both compounds have primary excitation peaks below 500nm, it can be 
assumed the Cherenkov-excitation must originate within 1mm (defined as d0 in Table 1) due 
to the attenuation of shorter wavelengths in tissue.
Tissue Optics
Tissue optical properties from previously published Monte Carlo simulations of photon 
interactions with a multi-layer skin model were adapted for the present investigation.2 The 
spectral distribution of the absorption coefficient (μa) and the reduced scattering coefficient 
(μs’) were used to calculate the effective attenuation coefficient (μeff) using (1):
μeff (mm
−1) = 3μa(μa + μs′) (1)
For a diffuse approximation of the number of photons present at a given distance the Beer-
Lambert Law can be applied with the effective attenuation coefficient as shown in (2):
Id1
= I0exp
−d1μeff (2)
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Where d1 is the distance (mm) from the photon source to tissue surface and I0 is the number 
of photons at the source. This approximation can be applied to estimate either the number of 
Cherenkov photons, or the number of Cherenkov-excited luminescent photons which reach 
the surface.
System Configuration
Two specific combinations of camera position and lens specification were considered as a 
way to demonstrate practical set ups. First, a 135mm f/1.8 lens positioned 1.3m from the 
target, and secondly a 50mm f/1.2 lens positioned 0.63m from the target. The numerical 
aperture can be approximated from the f-number using (3) and (4) to determine the 
acceptance angle:
NA 12 ∗ f _number (3)
θ = sin−1(NA) (4)
Since it was assumed that the light at the surface of the target tissue would emit light 
isotopically, only half the emitted light would leave the tissue and the total light captured by 
the lens (Nlens) must be adjusted using (5):
Nlens =
2θ
π (5)
The photons would then diffuse from the source proportional to 1/d22, where d2 is the 
distance from the target to the lens, assuming each point on the tissue acts like an isotropic 
emitter. Since the 50mm f/1.2 lens positioned 0.63m collects more photons, only values 
using this lens configuration are reported in the simulation output files (S2–S3). 
Additionally, experimental validation reported in subsequent sections uses a 50mm f/1.2 at 
this approximate distance.
Image Intensifier
The photocathode QE is applied to the number of photons collected by the lens to determine 
the number of electrons entering the next stage of the intensifier. The current photon budget 
assumed that the photocathode is a filmless Gen III device with high red quantum 
efficiency21, so that the photocathode introduces noise in the form of EBI, which is near 
0.02 photoelectrons/pixel/second at room temperature and an order of magnitude lower with 
active cooling.21 So, the total input EBI (NEBI) is calculated using (6):
NEBI = EBI(e/p/s) ∗ N pixels ∗ t(sec) (6)
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Where Npixels is 4 because of the 2×2 pixel binning, and t is the total exposure time while 
the intensifier is on, which is the product of the gate width and number of accumulations on 
chip (AOC).
Multiple stages of MCPs can be chained together where typical amplification values are 
approximately 104 (single stage), 106 (double stage), 107 (triple stage). These amplification 
values are used to determine the number of detected electrons which interact with the 
phosphor screen. The amplification is also applied to NEBI to determine the background 
noise levels.
Two phosphor screens were considered: P43 and P46. P43 has a higher quantum efficiency 
(200 photons/electron) but a longer decay time (1.5–3.2 ms), whereas P43 has a lower 
quantum efficiency (95 photons/electron), but quicker decay time (0.2–20 us).22 The P43 
and P46 phosphor screens emit photons at different wavelengths, which must be considered 
when factoring the CCD detection QE.
CCD Sensor
The CCD can be coupled to the intensifier by fibers, or with an air gap. The former is 
slightly more efficient, but with added cost, whereas the latter is more economical, but less 
efficient. A coupling efficiency of 50% is used in this budget. The noise characteristics of 
the CCD must also be combined with the EBI noise introduced at the photocathode. The 
CCD noise is characterized as shot noise (σS), which is defined by the square root of the 
number of incident photons, and dark current noise (σD) which is provided as a device 
specification.21 The total CCD noise is given by (7):
NoiseCCD = σS
2 + σD
2 (7)
While the CCD noise, combined with the EBI provides a lower limit of detection, the full-
well capacity of the CCD pixel provides and upper limit, and the current budget assumes a 
full well capacity of 130 ke− per pixel.21 Since 2×2 pixel binning is assumed, this value is 
quadrupled. After the CCD converts the photons to electrons, the analog-to-digital converter 
(ADC) will introduce a certain amount of uncertainty, between 10 e− and 70 e−, based on the 
rate of conversion, between 2 MHz and 32 MHz, respectively.21
Phantom Imaging
A mouse phantom (XFM-2X Fluorescence Phantom, PerkinElmer) with μeff ∈ [0.1, 3] mm
−1
, and spectral response similar to tissue, was used for experimental validation of the 
Cherenkov photon sensitivity. As shown in Figure 1, a linear accelerator (Varian, Clinac 
2100C, California, USA) produced a 6MV X-ray photon beam which was shaped by the 
multi-leaf-collimator (MLC) into a 5mm thick sheet across the midline of the phantom. A 
PiMAX4 ICCD (Princeton Instruments, New Jersey, USA) was triggered by the LINAC to 
acquire images 0.03μs after the beginning of the radiation pulse and for a gate width of 
3.25μs, which is within the duration of each radiation pulse. The number of AOC was 
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varied, while keeping the total dose fixed at 100MU (1Gy). The photocathode was not 
actively cooled during imaging, but the CCD was kept at −20°C.
In vivo Imaging
Human breast adenocarcinoma (MDA-MB-231) cells were implanted subcutaneously in two 
locations on the left and right lower flank of two nude mice. The tumors were allowed to 
grow until they were visible, but not ulcerated, approximately 100–250 mm3. Each mouse 
was anesthetized using isoflurane during imaging and placed prone on a black surface. Each 
tumor was injected with 50μL of a 50μM solution of each phosphorescent compound (0.25 
nmol). Imaging was performed during anesthesia and 30 minutes after sacrifice, and a 
warming pad was used to regulate the mouse temperature for the duration of imaging.
Similar to the ex vivo phantom imaging, a linear accelerator produced a 6MV X-ray photon 
beam which was shaped by the multi-leaf-collimator (MLC) into a 5mm thick sheet. 
However, in this experiment the radiation sheet traveled orthogonally from the ventral to 
dorsal region of the mouse, scanning from a position cranial to the tumor and moving in the 
caudal direction. A PiMAX4 ICCD was triggered by the LINAC to acquire images 4.26μs 
after the beginning of the pulse, so each frame is collected after the radiation pulse. Data 
from approximately 65 pulses were accumulated on chip before being read off the CCD. The 
gate width was between 5 and 10 times the deoxygenated effective lifetime of the given 
phosphorescent compound. The photocathode was not actively cooled during imaging, but 
the CCD was kept at −20°C.
Results and Discussion
The parameters considered for each component of the imaging system are presented in Table 
1, with corresponding typical ranges expected in EBRT. The associated quanta estimates 
using these ranges are also provided to demonstrate the magnitude of changes between 
elements. A more detailed breakdown of these interactions using a specific set of input 
parameters are provided in the following sections and the supplementary material.
Cherenkov Emission
The Cherenkov photon density in tissue due to a 6MV photon beam is given in Figure 2A 
for doses ranging from 0.03cGy to 2Gy. Tissue acts as a long pass filter as can be seen in 
Figure 2B and 2D. Shorter wavelength light is attenuated, so even though more Cherenkov 
photons are generated at shorter wavelengths, much of the detected signal originating from 
depths greater than 1mm in the tissue will be due to longer wavelengths. Figure 2D shows 
the Cherenkov photon budget for a source 3mm deep in tissue, where wavelengths shorter 
than 600nm are just above the noise floor, whereas wavelengths longer than 600nm are 
about two orders of magnitude above the noise floor. If we assume 30 pulses, corresponding 
to a dose of 0.83cGy, are accumulated on chip, then there are enough Cherenkov photons to 
be distinguished from the background, as shown in Figure 2D where all the lines are above 
the silver shaded region at the CCD.
Camera properties, such as lens placement also have a large impact on the detectable signal. 
Without accounting for distance, the f/1.2 lens can capture a maximum of 27.4% of the 
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emitted light, while the f/1.8 captures up to 17.9%, however, when distance to the object is 
considered, the intensity obeys an inverse square relation, dramatically reducing the detected 
signal. The photon budget indicates the lens may only receive approximately a single photon 
for each binned-pixel. While this value is small, the intensifier can amplify the signal 
sufficiently for detection by the CCD.
The first stage of the intensifier, the photocathode, introduces a small amount of background 
intensity. The EBI is also amplified through the next two stages of the intensifier, depicted 
by the silver shaded region in Figures 2D and 3D. Cooling can help reduce the EBI by 
reducing the background by 10–20×, however this has little impact on the detectable 
Cherenkov signal as shown in Figure 4 where the ratio remains the same after cooling.
Cherenkov-excited Luminescence
While it is possible to detect Cherenkov-photons with sufficient signal at depths of 
centimeters, it is not an ideal modality for targeted imaging often used to determine 
properties of subcutaneous lesions. Phosphorescent compounds can be used to absorb 
Cherenkov photons in tissue at depths of greater than a centimeter. The two compounds 
investigated in this study, PtG4 and Ir(btp)2(acac) absorb photons at shorter wavelengths and 
emit longer wavelengths after the 4μs radiation pulse has stopped. Figure 3A shows the 
excitation and emission spectrum of PtG4, where the excitation overlaps with much of the 
Cherenkov emission. Even though both these compounds have quantum yields much lower 
than 1, the longer wavelengths are less affected by tissue attenuation and there is still 
sufficient signal for detection. The number of phosphorescence photons originating from a 
10uM PtG4 inclusion at various tissue depths (d1) is shown in Figure 3B. Since the 
phosphorescence shifts the output to a longer wavelength, there are no photons within the 
400–500 or 500–600nm range shown beyond the Cherenkov source for the photon budget 
depicted in Figure 3D. Additionally, for this compound the photons between 600–700nm are 
not detectable without further processing because they are below the noise floor, shown as 
the silver shaded region.
As with the Cherenkov detection, the distance from the camera to the object of interest (d2) 
has a very strong influence on the final signal due to the 1/d22 relation. Since 
phosphorescence imaging has a lower overall signal than Cherenkov imaging, camera 
placement is one method that could greatly improve system sensitivity.
Since phosphorescence images are acquired after the 4μs radiation pulse and generally have 
a longer gate width (55μs–300μs), the EBI will have a larger influence because this 
background signal is directly related to the gate width and the number of accumulations on 
chip. The estimated signal and background intensities based on the simulated photon budget 
are summarized in Table 2 and used to calculate the signal-to-background ratios in Figure 4. 
Since EBI impacts phosphorescence detection more so than Cherenkov detection, 
background reduction through photocathode cooling will more positively influence CEL 
imaging, as can be seen in Figure 4. Without cooling, the photon budget indicates 
Ir(btp)2(acac) is detectable at depths of approximately 3.5mm in tissue, and PtG4 is 
detectable at depths of approximately 3mm, however, with cooling these values increase to 
8mm and 10mm, respectively. The difference in slope is due to the comparison of different 
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wavelength ranges, where both Cherenkov and PtG4 have their highest SBR in the 700–
800nm range, whereas Ir(btp)2(acac) has a peak emission at 620nm, so the 500–600nm 
range was used to compute SBR for this compound.
Experimental validation
Phantom Imaging—Images of the mouse phantom acquired during the radiation pulse 
show detectable Cherenkov signal. As the number of AOC are increased, the image signal 
increases as seen in Figures 5. Higher AOC increase the signal intensity, but also increase 
radiation dose and background intensity levels.
To further quantify the relation of the signal and background, two regions of interest were 
defined for each image stack. The Cherenkov signal is defined as the region within the white 
boundary in Figure 6A, which is where the radiation beam is delivered to the mouse 
phantom. The background is defined as the region outside of the green boundary around the 
mouse phantom. The normalized distribution of pixel intensities for each region are shown 
for a Cherenkov image collected using 2 AOC as shown in Figure 6A–C. The distribution of 
the background appears Gaussian and pixel intensity is centered at 600 counts, which is the 
offset used by the PiMAX, whereas the distribution of the detected Cherenkov photons 
centered at 705 and follows a Poison distribution. As the number of accumulations increases, 
the variability of the pixel intensities for both regions grow, however it increases more 
rapidly for the background region. The ratios of the median pixel intensity for each region 
provides the signal-to-background ratio, as shown in Figure 6E for a single frame. Since 
there is an offset used in the camera, the signal-to-noise ratio is calculated as:
SNR = Med(Beam) − 600σBg
(8)
where σBg is the standard deviation of pixel intensities in the background region. While both 
SBR and SNR increase with the number of AOC, the radiation dose required to capture each 
image also increases as shown in the upper x-axis of Figures 6D and 6E. The SNR was also 
determined for a fixed radiation dose of just under 7cGy by taking the temporal median of 
the acquired image frames, where 2 frames were used from the set of images acquired with 
128 AOC, and 128 frames were used from the set acquired with 2 AOC. These parameters 
more closely match previously reported acquisition settings where temporal median filtering 
is often used to reduce noise from high-energy particles.8,14,17 In this setting it can be seen 
in Figure 5E that the SNR plateaus between 64 and 128 AOC.
In this phantom study, the image stacks captured with lower AOC values have lower photon 
flux due to the shorter CCD exposure times. In this region (<64 AOC) the primary factors 
contributing to noise are dark current and read noise from the ADC. In the read-noise-
limited detection the signal is expected to increase linearly with the number of exposures, 
while the noise remains relatively constant. So, in this region, combining multiple exposures 
will increase the SNR by the square root of the number of exposures. However, as the 
photon flux increases with longer CCD exposure times (>64AOC), the primary factors 
contributing to noise are EBI from the photocathode and shot-noise in the CCD. In this 
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photon-limited-noise region combining additional frames does not improve the overall SNR, 
as seen in Figure 6E. While the SNR should remain relatively unchanged, a single frame 
may still contain artifacts from high-energy particles, so in practice multiple frames are still 
acquired using a temporal median filter to reduce their influence on the final image.
In vivo imaging
Data collected from in vivo imaging of mice with subcutaneous tumors injected with PtG4 
and Ir(btp)2(acac) produce a detectable signal in a single frame. Tumors were estimated to 
be between 100 and 250 mm3 which corresponds to an approximate average dimension 
between 4.6 and 6.3 mm.
Approximating the thickness of mouse skin to be between 0.5 and 1.5 mm, and assuming 
there is additional tissue between the surface and tumor, we can estimate the phosphorescent 
signal will diffuse between 1 and 4mm in tissue before reaching the surface. From Figure 4 
we see the estimated signal-to-background ratio in this range is estimated to be between 3.0 
– 1.1 and 6.5 – 1.3 for PtG4 and Ir(btp)2(acac), respectively.
A single frame for both Cherenkov and PtG4 phosphorescence detection are shown in Figure 
7B and C, respectively. The Cherenkov image was collected using 32 accumulations on chip 
with a gate width of 3.5us, for a total dose of 0.89cGy. The phosphorescence frame was 
collected with 64 accumulations on chip and a gate width of 300us, for a total dose of 
1.78cGy. From these images, we observe the Cherenkov pixel intensity values are on the 
order of 104 counts, whereas the phosphorescence is an order of magnitude weaker, even 
though the Cherenkov image received half the dose. While the photon budget indicates the 
Cherenkov pixel intensity should be approximately 100× higher than the PtG4 intensity for 
equal radiation dose, as shown in Table 2, or 50× for half the dose, the in vivo PtG4 is 
localized below the skin whereas the Cherenkov originates at multiple locations within the 
mouse, which can account for the slight discrepancy.
While the photon budget indicates Cherenkov imaging exhibits a relatively strong signal 
with low background, the impact of high-energy particles observed as high-intensity speckle 
(Figure 7B) cannot be fully ignored, however, it can be overcome with temporal-median 
filtering. The short gate width and low number of accumulations needed to acquire an 
adequate Cherenkov frame help keep the background levels low, although higher photon 
counts will increase the CCD shot noise which can explain why in Table 2 Ir(btp)2(acac) has 
lower noise than the Cherenkov image, even though the CEL image uses a longer gate 
width.
Regions of interest for each tumor were created from a processed image set. Briefly, a 
processed image set is created by temporally and spatially median filtering multiple frames. 
Temporal median filtering can be achieved because the MLC scans the radiation beam 
across the midline of the mouse and multiple frames are acquired at each MLC position, 
which provides the opportunity to take the median of sequential frames. A maximum 
intensity projection is performed on the resulting image stack, and a threshold is used to 
identify the area of maximum phosphorescence (white boundary in Figure 7D). The 
background is defined as the area outside of the tumor regions and is also overlaid as the 
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darker area around the tumors in the phosphorescence frame shown in Figure 7D. There is a 
small amount of padding between the tumor and background regions to avoid diffusion of 
the phosphorescent signal and to account for a certain amount of uncertainty in tumor and 
injection locations. The median value of each region is determined for each frame and these 
values were used to calculate the SBR. The PiMAX4 adds an arbitrary offset to the pixel 
values of approximately 600 counts, so this is accounted for in this experiment by 
subtracting the background minimum from both regions in the same frame as shown in (9).
SBR = Med(Tumor) −Min(Bg . )Med(Bg . ) −Min(Bg . ) (9)
The maximum experimentally determined SBR for PtG4 was found to be between 2.1 and 
2.2, and between 1.8 and 1.9 for Ir(btp)2(acac), which are both within the estimated ranges 
of the photon budget. Additionally, if we subtract the arbitrary offset, the median pixel 
values for the tumors are similar to those estimated by the photon budget, with the photon 
budget only slightly underestimating the actual values.
While phosphorescence lifetime is not directly considered in the photon budget, 
experimentally the gate width is generally set between 5–10 times the deoxygenated lifetime 
(τ0). By accounting for gate width in the photon budget, we are indirectly compensating for 
the needed shift in detection time. While this works to reduce the noise floor, as can be 
observed when comparing the estimated noise intensity of PtG4 and Ir(btp)2(acac) (Table 2), 
there are practical limitations in applicable lifetimes.
The time between radiation pulses is one factor that will limit the maximum lifetime when 
choosing a phosphorescent compound. The LINAC generates radiation pulses at a repetition 
rate between 2.7 and 17ms (600MU/min–100MU/min), where the slower rates require 
longer treatment times, which can be impractical for in vivo imaging applications. 
Additionally, the phosphor plate in the image intensifier also has a decay which is generally 
provided in technical specifications. For example, P43 the decay to 10% or 1% the original 
signal is 1.5 and 3.2 ms, respectively, whereas P46 is ranges from 0.2 and 20 μs at the 
sacrifice of quantum efficiency and spatial resolution.22 In the current experiments a dose 
rate of 500MU/min, corresponding to a repetition rate of 3.3ms, was used to reduce the 
impact of ghosting between frames, which could be introduced at higher dose rates due to 
the limitations of the P43 decay time.
Shorter lifetimes can be difficult to discriminate from the radiation-induced Cherenkov light. 
The LINAC radiation pulse does not immediately turn off, and both stray charge and 
Cherenkov emissions may be detected during the transition phase. Phosphorescent 
compounds with lifetimes in this range (<4.5us) will be difficult to detect. While 
Ir(btp)2(acac) has a deoxygenated effective lifetime beyond this range, when it is in a well-
oxygenated environment it may be more difficult to detect, whereas PtG4 can be detected 
both in the presence and absence of oxygen.
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Conclusions
Imaging system
There are many factors that influence the detection of Cherenkov emission and Cherenkov-
excited luminescence in vivo. While there are detectable signals in both imaging modalities, 
photon flux during imaging can be very close to the noise floor, but discriminating the signal 
from the noise can be improved by optimizing several camera parameters. Phantom 
experiments demonstrated how SNR saturates when increasing the camera AOC value. This 
is thought to be the transition between the read-noise-limited and photon-noise-limited 
regimes. This transition point is where the SNR can be maximized without unnecessary 
increases to radiation dose. However, the transition point will change based on camera 
parameters such as positon, ADC rate, and cooling temperature, as well as the inherent 
photon flux of the system being imaged.
As can be observed in Table 1, and Figures 2C and 3C, detection signal is most sensitive to 
camera-to-target distance. The inverse square relation of distance from the source can be 
accommodated by designing the optical path such that the camera is placed proximal to the 
target, without placing the camera hardware in the path of the radiation beam.
While the intensifier can overcome the low photon count, the CEL signals are still very low 
and the system is noise-limited. While additional MCP stages could theoretically help 
improve the overall signal, this comes at great cost. Additionally, if the EBI is greater than 
the photon count at the photocathode, additional MCP stages will not improve the problem. 
Maintaining low noise levels is particularly important with CEL imaging, where 
photocathode cooling may produce an up to 3× increase in depth sensitivity.
In vivo properties
While we have observed in vivo Cherenkov emission to be on the order of 100× stronger 
than Cherenkov-excited phosphorescence for the compounds discussed in this investigation, 
much of Cherenkov light is being absorbed by nearby tissue, and thus never reaches the 
surface for detection. This absorption-dominated process can still be leveraged by localizing 
compounds which shift this energy to longer wavelengths which are impacted less by 
absorption. At these longer wavelengths, light attenuation in tissue is dominated by scatter 
and can travel further distances.
Tissue optical properties have a large impact on the overall signal, which is observed at 
greater depths. This is less of a concern for the implementation of Cherenkov for surface 
dosimetry. However, using CEL the detection of signals at depths is generally very 
important. One method to reduce the impact of this issue is to identify a phosphorescent 
compound with an emission less influenced by absorption. As can be seen in Figure 4 
Ir(btp)2(acac) has a more negative slope than PtG4, so while Ir(btp)2(acac) has a slightly 
higher SBR at shallow depths, PtG4 is more robust at depth due to its emission peak at 772 
nm, as opposed to the Ir(btp)2(acac) emission peak at 620nm.
To optimize CEL, compounds which are excited by wavelengths shorter than approximately 
500nm should be located as close to the targeted tissue as possible to maximize the energy 
LaRochelle et al. Page 13
Phys Med Biol. Author manuscript; available in PMC 2019 April 20.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
transfer. The multiple dendritic chains of PtG4 allow it to circulate in blood with little 
degradation, whereas Ir(btp)2(acac) can be endocytosed by cells.20,23 While both methods 
can deliver the compound to the tumor microenvironment, they are not molecularly targeted, 
which could further enhance the in vivo applications of CEL imaging.
Model
The current investigation was limited to Cherenkov detection, and detection of CEL for two 
specific phosphorescent compounds. The input parameters for this model are organized in a 
single spreadsheet (S1), which allows for easily incorporating changes to the imaging 
environment. Additionally, simulating other compounds with known extinction coefficient, 
quantum yield, and lifetime would be trivial, as no code would need to be modified. While 
more detailed Monte Carlo simulations could be developed, the current model provides an 
estimate of which compounds warrant further investigation.
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Figure 1. 
Geometry of the imaging system used for experimental validation. The LINAC gantry head 
is placed below the subject, providing a source of high energy photons. The subject is placed 
on the treatment couch with a mirror above to redirect photons towards the camera. (A) 
Side-view representation of the mouse phantom showing the radiation sheet in red. The 
mouse is placed on a 0.5–1.0cm thick water phantom to account for the buildup region of the 
radiation dose. (B) Top-view or camera-view representation of the mouse as seen by the 
ICCD with the radiation sheet superimposed.
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Figure 2. 
(A) Cherenkov photons produced in 1 mm2 as the result of: a single radiation pulse 
(0.03cGy), 30 pulses (0.83cGy), 60 pulses (1.67cGy), and 7200 pulses (2Gy). (B) 
Cherenkov photon attenuation of 30 pulses (0.83cGy) observed at the tissue surface for 
photons emitted at various depths (d1). (C) Schematic depicting imaging system and 
components of interest. (D) Photon budget for a Cherenkov source at 3mm below the tissue 
surface (d1) generated by a 0.83cGy dose, as detected by a 2×2 binned-pixel. The blue 
dotted line at right represents the usable dynamic range of the sensor.
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Figure 3. 
(A) Approximate tissue attenuation coefficients overlaid with extinction coefficient for 
10μM PtG4 (left y-axis), and corresponding normalized emission spectrum (right y-axis). 
(B) Simulated photon count of CEL caused by 0.83cGy dose for a PtG4 source at various 
depths (d1) within tissue. (C) Schematic depicting imaging system and components of 
interest. (D) Photon budget for PtG4 CEL source at 3mm below the tissue surface (d1) 
generated by a 0.83cGy dose, as detected by a 2×2 binned-pixel. The blue dotted line at right 
represents the usable dynamic range of the sensor.
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Figure 4. 
Theoretical Signal-to-Background ratio for Cherenkov and CEL detection with a 
photocathode room temperature, and cooled with dry nitrogen. Cherenkov values are the 
same.
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Figure 5. 
Cherenkov image frames of a mouse phantom captured with varying numbers of 
accumulations on chip (AOC).
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Figure 6. 
(A) Cherenkov image frame of a mouse phantom captured using 2 accumulations on chip; 
(B) Normalized histogram of intensity count for region of image receiving radiation dose 
(inside white area in (A)); (C) Normalized histogram of intensity count for background area 
around mouse phantom (outside green area in (A)); (D) Median pixel intensity of previously 
defined regions for different AOCs, where error bars show standard deviation of pixel 
intensities in region; (E) Signal-to-background ratio and signal to noise ratio for varying 
AOCs
LaRochelle et al. Page 21
Phys Med Biol. Author manuscript; available in PMC 2019 April 20.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 7. 
(A) Room-light image of mouse with two flank tumors injected with PtG4. (B) Single 
Cherenkov frame of interest during scanned imaging. (C) Single phosphorescence frame. 
(D) Regions of interests identified on phosphorescence frame, which were used to generate 
values shown in table.
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